FINWIRES · TerminalLIVE
FINWIRES

$ADIL

4 stories mentioning ADIL

Every FINWIRES story that references ADIL, newest first.

Sectors

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 3%.In corporate news, Adial Pharmaceuticals (ADIL) shares surged 45% after it said Thursday it has acquired Azora Therapeutics, a biopharmaceutical company developing treatments for serious inflammatory diseases.Novartis (NVS) shares gained 4.2% after the company said a phase 1/2 trial of its experimental treatment del-brax met both primary and key secondary endpoints in people with facioscapulohumeral muscular dystrophy.Novo Nordisk (NVO) won approval from UK regulators for its Wegovy pill, a daily oral version of semaglutide, for weight management in adults with obesity or overweight and a weight-related condition. Novo shares rose 2.8%.Some employers in the US intend to drop coverage of GLP-1 medications for weight loss in 2027 amid the increasing popularity of Novo Nordisk's Wegovy and Eli Lilly's (LLY) Zepbound and Foundayo, Reuters reported, citing the Business Group on Health, a policy research group for large employers. Lilly shares were up 2.9%.

$ADIL$LLY$NVO$NVS
Sectors

Sector Update: Healthcare

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index adding 1.3% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 1.3%.The iShares Biotechnology ETF (IBB) climbed 2.9%.In corporate news, Adial Pharmaceuticals (ADIL) shares surged 41% after it said Thursday it has acquired Azora Therapeutics, a biopharmaceutical company developing treatments for serious inflammatory diseases.

$ADIL
Wire

Top Midday Gainers

Propanc Biopharma (PPCB) approved a share repurchase program to buy back up to $5 million of common stock, the company said Thursday.Shares soared 124% as intraday trading volume catapulted to over 155.6 million from a daily average of about 130,000.Adial Pharmaceuticals (ADIL) said Thursday it has acquired Azora Therapeutics, a biopharmaceutical company developing treatments for serious inflammatory diseases.Shares soared 30% amid a surge in intraday trading volume to over 16.5 million from a daily average of roughly 118,000.Applied Materials (AMAT) expanded manufacturing and research & development operations in Singapore with a $500 million facility in Tampines to support AI-driven semiconductor demand.Shares jumped 8.5% following an increase in intraday trading volume to over 5.3 million from a daily average of about 7 million.Price: $3.04, Change: $+1.69, Percent Change: +124.81%

$ADIL$AMAT$PPCB
Wire

Adial Pharmaceuticals Acquires Azora Therapeutics

Adial Pharmaceuticals (ADIL) said Thursday it has acquired Azora Therapeutics, a biopharmaceutical company developing treatments for serious inflammatory diseases.Adial said it also entered into a definitive agreement for a private placement of up to $64 million in gross proceeds before expenses, including an initial financing of about $32 million. An additional $32 million could be raised upon the initiation of a phase 1 clinical study in exchange for further pre-funded and common warrants, the biopharmaceutical company said.The combined company expects to use the funding primarily to advance Azora's AT177 program through key clinical milestones, including studies required to file an investigational new drug application and clinical trials.Shares of Adial rose over 19% in Thursday trading.Price: $2.58, Change: $+0.42, Percent Change: +19.44%

$ADIL